Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Mar 25.
Published in final edited form as: Cell Cycle. 2010 Jun 1;9(11):2249–2250. doi: 10.4161/cc.9.11.11621

Androgen Receptor Responsive Enhancers are flanked by Consistently-Positioned H3-Acetylated Nucleosomes

Benjamin P Berman 1, Baruch Frenkel 2, Gerhard A Coetzee 3,**, Li Jia 3,*
PMCID: PMC4373526  NIHMSID: NIHMS671884  PMID: 20495358

Chromatin is remodeled and nucleosomes repositioned at genomic elements such as active gene promoters1 and CTCF insulators2 to create nucleosome free regions (NFR). In the case of promoters, this may be caused by RNA polymerase II occupancy and the initiation of divergent transcription, implicating the polymerase starting and then pausing transcription in opposite directions1. Chromatin states at transcriptional enhancers are less well characterized. Active enhancers most likely loop to engage target gene promoters and modulate cell type-specific gene expression3, but nucleosome positioning in relation to transcription factor occupancy has not been studied extensively at enhancers. The relative positioning of transcription factors and nucleosomes at enhancer regions may well be a pivotal factor influencing transcriptional competency. Recent advances in ChIP-seq technology have allowed precise, high-resolution genome-wide nucleosome location assessments and revealed NFRs at both promoters and enhancers4. Here, we show data obtained from a ChIP-seq analysis of histone H3K9,14 acetylation (H3K9,14ac) and androgen receptor (AR) occupancy in cultured prostate cancer cells (LNCaP) after a 4-hour treatment of the cells with the natural AR ligand, dihydrotestosterone (DHT) (Figure 1). We carefully inspected two known AR target genes (KLK3 & KLK2) that have well-characterized DHT-responsive enhancers a few kilobases upstream from their respective TSSs5. As previously shown6, 7, H3K9, 14ac signals populated the two loci at the respective gene bodies and enhancers, while AR occupancy showed strong signals at the enhancers and weaker signals at the gene promoters (i.e. the TSS). Unexpectedly, in the ChIP-seq data clear ‘troughs’ were observed not only at the promoters, but even more clearly at the two known enhancers, with AR precisely located between the two H3K9,14ac peaks that form the ‘trough’. Based on the similarity of this pattern to promoters, these H3K9,14ac ‘troughs’ are highly suggestive of positioned nucleosomes flanking an NFR in the enhancers, with AR binding at the NFR. We are in the process of establishing the temporal order of AR occupancy versus histone modifications and NFR formation at these and other enhancers. It is tempting to speculate that AR occupancy drives the histone acetylation and the subsequent creation of NFRs at enhancers in a manner similar to RNA polymerase II affecting promoters, although earlier remodeling steps by FoxA18 or other factors should not be excluded. Another scenario is that AR occupies sites that do contain nucleosomes, but selectively promotes histone acetylation of flanking nucleosomes only – this interpretation is consistent with what is known about liganded AR recruiting acetyl transferases such as p300/CBP to genomic sites9. In summary, the findings reported here contribute new insight into the structural dynamics of enhancer regions and their interaction with transcription factors and chromatin structure.

Figure 1.

Figure 1

ChIP-seq data from LNCaP cells treated for 4 hours with 10nM DHT. Single-end 36-bp sequence tags were aligned to the NCBI 36 genome using Maq10, and the density of correctly oriented tags within sliding 500-bp windows was used to create wiggle tracks on the UCSC genome browser. Densities are presented as the average number of tags per base pair.

Acknowledgments

The authors thank the USC Epigenome Center, and its support from the Norris Foundation, for high-throughput sequencing and data processing. The work was supported by the Whittier Foundation and grants from the NIH to GAC (R01 CA 109147 and R01 CA 136924).

Footnotes

NO CONFLICT-OF-INTEREST AND FINANCIAL DISCLOSURE

References

  • 1.Seila AC, Core LJ, Lis JT, Sharp PA. Divergent transcription: a new feature of active promoters. Cell Cycle. 2009;8:2557–64. doi: 10.4161/cc.8.16.9305. [DOI] [PubMed] [Google Scholar]
  • 2.Fu Y, Sinha M, Peterson CL, Weng Z. The insulator binding protein CTCF positions 20 nucleosomes around its binding sites across the human genome. PLoS Genet. 2008;4:e1000138. doi: 10.1371/journal.pgen.1000138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature. 2009;459:108–12. doi: 10.1038/nature07829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, et al. Dynamic regulation of nucleosome positioning in the human genome. Cell. 2008;132:887–98. doi: 10.1016/j.cell.2008.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jia L, Berman BP, Jariwala U, Yan X, Cogan JP, Walters A, et al. Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. PLoS ONE. 2008;3:e3645. doi: 10.1371/journal.pone.0003645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jia L, Shen HC, Wantroba M, Khalid O, Liang G, Wang Q, et al. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol. 2006;26:7331–41. doi: 10.1128/MCB.00581-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang Q, Carroll JS, Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell. 2005;19:631–42. doi: 10.1016/j.molcel.2005.07.018. [DOI] [PubMed] [Google Scholar]
  • 8.Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008;132:958–70. doi: 10.1016/j.cell.2008.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Mol Cancer Res. 2003;1:385–92. [PubMed] [Google Scholar]
  • 10.Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008;18:1851–8. doi: 10.1101/gr.078212.108. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES